Spectral AI (MDAI) Stock Analysis & Winston Score
Spectral AI is a small medical technology company that makes a device to help doctors treat burn wounds. Its main product, DeepView, uses light and artificial intelligence to scan a burn injury and predict whether it will heal on its own or need surgery. The main customers are hospitals, burn centers, and military medical units. The company earns revenue by selling or licensing its DeepView system, and it has received funding from the U.S. Department of Defense to develop the technology for battlefield use. Spectral AI operates primarily in the United States and is still in an early commercial stage, which explains its deeply negative operating margins and very high cash burn. The biggest risk the company faces is proving that enough hospitals will pay for the device at scale, since it has not yet reached consistent revenue to cover its operating costs.
Winston Score: 19/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (6/30)
- Growth: Weak (2/20)
- Cash Flow: Weak (0/10)
- Stability: Data not available (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)
